Arrhythmia and right heart disease: From genetic basis to clinical practice;Arritmias y enfermedades del corazón derecho: de las bases genéticas a la clínica

Revista Espanola de Cardiologia

Volumn 63, Issue 8, 2010, Pages 963-983

  Capulzini, Lucio ^a   Brugada, Pedro ^a   Brugada, Josep ^b   Brugada, Ramon ^c  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF GIRONA   (Spain)

Author keywords

Arrhythmogenic right ventricular dysplasia; Brugada syndrome; Idiopathic right ventricular tachycardia; Sudden cardiac death

Indexed keywords

ANTIARRHYTHMIC AGENT; QUINIDINE;

ATHLETE; BRUGADA SYNDROME; CATHETER ABLATION; CLINICAL PRACTICE; CONGENITAL HEART DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FALLOT TETRALOGY; GENETICS; HEART ARRHYTHMIA; HEART DISEASE; HEART RIGHT VENTRICLE DYSPLASIA; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; LIFESTYLE MODIFICATION; PATHOGENESIS; REVIEW; SCREENING TEST; SPORT; SUDDEN DEATH;

EID: 77957158672     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(10)70208-6     Document Type: Article

References (119)

1. R. Frank, and G. Fontaine Electrocardiologie de cas de dysplasie ventriculaire droite arythmogene Arch Mal Coeur Vaiss 71 1978 963 972
2. G. Thiene, A. Nava, D. Corrado, L. Rossi, and N. Pennelli Right ventricular cardiomiopathy and sudden death in young people N Engl J Med 318 1988 129 133
3. P. Gallo, G. D'Amati, and F. Pelliccia Pathologic evidence of extensive left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy Hum Pathol 23 1992 948 952
4. G. Thiene, and C. Basso Arrhythmogenic right ventricular cardiomyopathy: an update Cardiovasc Pathol 10 2001 109 117
5. F.I. Marcus, G.H. Fontaine, G. Guiraudon, R. Frank, J.L. Laurenceau, and C. Malergue Right ventricular dysplasia: a report of 24 adult cases Circulation 65 1982 384 398 (Pubitemid 12219036)
6. N. Protonotarios, A. Tsatsopoulou, P. Patsourakos, D. Alexopoulos, P. Gezerlis, and S. Simitsis Cardiac abnormalities in familial palmoplantar keratosis Br Heart J 56 1986 321 326
7. F. Corrado, G. Fontaine, F.I. Marcus, W.J. McKenna, A. Nava, and G. Thiene Arrhythmogenic right ventricular dysplasia/cardiomiopathy:need for international registry. Study group on arrhythmogenic right ventricular dyspalsi/cardiomiopathy of the working groups of myocardial and and pericardial disease and arrhythmias of the European Society of Cardiology and the Scientific Council of Cardiomyopathies of the World Heart federation Circulation 101 2000 E101 E106
8. A. Rampazzo, A. Nava, S. Malacrida, G. Beffagna, B. Bauce, and V. Rossi Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy Am J Hum Genet 71 2002 1200 1206
9. B. Gerull, A. Heuser, T. Wichter, M. Paul, C.T. Basson, and D.A. McDermott Mutations in the desmosomal protein plakophilin 2 are common in arrhythmogenic right ventricular cardiomiopathy Nat Genet 36 2004 1162 1164
10. P. Van der Zwaag, J. Jongbloed, M. Van den Berg, J. Van der Smagt, R. Jongbloed, and H. Bikker A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy Human Mutation 30 2009 1 6
11. G. Beffagna, G. Occhi, A. Nava, L. Vitiello, A. Ditadi, and C. Basso Regulatory mutations in transforming growth factor -beta3 gene cause arrhythmogenic right ventricular cardiomiopathy type 1 Cardiovasc Res 65 2005 366 373
12. N. Tiso, D.A. Stephan, A. Nava, A. Bagattin, J.M. Devaney, and F. Stanchi Identification of mutations in the cardiac ryanodine receptor genes infamilies affected with arrhythmogenic right ventricular cardiomiopathy type 2 (ARVD2) Hum Mol Genet 10 2001 189 194
13. N.D. Merner, K.A. Hodgkinson, A.F. Haywood, S. Connors, V.M. French, and J.D. Drenckhahn Arrhythmogenic right ventricular cardiomiopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene Am J Hum Genet 82 2008 809 821
14. S. Sen-Chowdhry, P. Syrris, and W. McKenna Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomiopathy J Am Coll Cardiol 50 2007 1813 1821
15. G. Thiene, D. Corrado, and C. Basso Arrhythmogenic right ventricular cardiomiopathy/dysplasia Orphanet J Rare Dis 14 2007 45
16. D. Corrado, C. Basso, G. Thiene, W.J. McKenna, M.J. Davies, and F. Fontaliran Spectrum of clinicophatologic manifestations of arrhythmogenic right ventricular cardiomiopathy/dysplasia: a multicenter study J A Coll Cardiol 30 1997 1521 1530
17. W.J. McKenna, G. Thiene, A. Nava, F. Fontaliran, C. Blomstrom- Lundqvist, and G. Fontaine Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology Br Heart J 71 1994 215 218
18. M.S. Hamid, M. Norman, A. Quraishi, S. Firoozi, R. Thaman, and J.R. Gimeno Prospective evaluation of relatives familial arrhthmogenic right ventricular cardiomiopathy/dyspalsia reveals a need to broaden diagnostic criteria J Am Coll Cardiol 40 2002 1445 1540
19. F.I. Marcus, W.J. McKenna, D. Sherrill, C. Basso, B. Bauce, and D. Bluemke Diagnosis of arrythmogenic right ventricular cardiomyopathy/dysplasia. Proposed modification of the Task Force criteria Circulation 2010 Feb 19 [Epub ahead of print]
20. F.I. Marcus, W. Zareba, H. Calkins, J.A. Towbin, C. Basso, and D.A. Bluemke Arrhythmogenic right ventricular cardiomiopathy/dysplasia clinical presentation and diagnostic eveluation: results from the North American Multidisciplinary Study Heart Rhythm 6 2009 984 992
21. L. Daliento, G. Rizzoli, G. Thiene, A. Nava, M. Rinuncini, and R. Chioin Diagnostic accuracy of right ventriculography in arrhythmogenic right ventricular cardiomyopathy Am J Cardiol 66 1990 741 745
22. E.E. Van der Wall, H.W. Kayser, M.M. Bootsma, A. De Roos, and M.J. Schalij Arrhythmogenic right ventricular dysplasia: MRI findings Herz 25 2000 356 364
23. D. Pennell, and G. Casolo Right ventricular arrhythmia: emergence of magnetic resonance imaging as an investigative tool Eur Heart J 18 1997 1843 1845 (Pubitemid 27526109)
24. H. Naito, J. Arisawa, K. Harada, H. Yamagami, T. Kozuka, and S. Tamura Assessment of right ventricular regional contraction and comparison with the left ventricle in normal humans: a cine magnetic resonance study with presaturation myocardial tagging Br Heart J 74 1995 186 191
25. K.R. Prakasa, D. Dalal, J. Wang, C. Bomma, H. Tandri, and J. Dong Feasibility and variability of three dimensional echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy Am J Cardiol 97 2006 703 709
26. H. Tandri, C. Bomma, H. Calkins, and D.A. Bluemke Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia J Magn Reson Imaging 19 2004 848 858 (Pubitemid 38788663)
27. H. Tandri, M. Saranathan, E.R. Rodriguez, C. Martinez, C. Bomma, and K. Nasir Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging J Am Coll Cardiol 45 2005 98 103 (Pubitemid 40052034)
28. P. Hunold, H. Wieneke, O. Bruder, U. Krueger, T. Schlosser, and R. Erbel Late enhancement: a new feature in MRI of arrhythmogenic right ventricular cardiomyopathy? J Cardiovasc Magn Reson 7 2005 649 655
29. A.P. Burke, A. Farb, G. Tashko, and R. Virmani Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? Circulation 97 1998 1571 1580
30. D. Corrado, C. Basso, L. Leoni, B. Tokajuk, B. Bauce, and G. Frigo Three-dimensional electroanatomical voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomiopathy/dysplasia Circulation 111 2005 3042 3050
31. D. Corrado, C. Basso, L. Leoni, B. Tokajuk, P. Turrini, and B. Bauce Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia J Am Coll Cardiol 51 2008 731 739
32. A.P. Wijnmaalen, M.J. Schalij, M. Bootsma, P. Kies, H. Putter, and J.J. Bax Patients with scar related right ventricular tachycardia: determinans of long-term outcome J Cardiovasc Electrophysiol 20 2009 1118 1127
33. C. Barahona-Dussault, B. Benito, O. Campuzano, A. Iglesias, T.L. Leung, and L. Robb Role of genetic testing in arrhythmogenic right ventricular cardiomiopathy dysplasia: experience from a single center prospective cohort Clin Genet. 2009 Oct 23. [Epub ahead of print]
34. A. Asimaki, H. Tandri, H. Huang, M.K. Halushka, S. Gautam, and C. Basso A new diagnostic test for arrhythmogenic right ventricular cardiomiopathy N Engl J Med 360 2009 1075 1084
35. A. Buja, N.A. Estes, T. Wichter, D. Corrado, F. Marcus, and G. Thiene Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy Prog Cardiovasc Dis 50 2008 282 293
36. J. Hulot, X. Jouven, J. Empana, R. Frank, and G. Fontaine Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomiopathy Circulation 110 2004 1879 1884
37. D. Corrado, L. Leoni, M.S. Link, P. Della Bella, F. Gaita, and A. Curnis Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomiopathy/dysplasia Circulation 108 2003 3084 3091
38. A. Roguin, C.S. Bomma, K. Nasir, H. Tandri, C. Tichnell, and C. James Implantable cardioverter-defibrillator in patients with arrhythmogenic right ventricular cardiomiopathy/dysplasia J Am Coll Cardiol 43 2004 1843 1852
39. T. Wichter, M. Paul, C. Wollmann, T. Acil, P. Gerdes, and O. Ashraf Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomiopathy: single center experience of long-term follow-up and complications in 60 patients Circulation 43 2004 843 852
40. T. Wichter, M. Borggrefe, W. Haverkamp, X. Chen, and G. Breithardt Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease: results in patients with inducible and noninducible ventricular tachycardia Circulation 86 1992 29 37
41. G. Marcus, D. Glidden, B. Polonsky, W. Zareba, L. Smith, and D. Cannom Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomiopathy J Am Coll Cardiol 54 2009 609 615
42. M. Arruda, T.F. Armaganijan, L. Di Biase, D. Patel, and A. Natale Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplsia J Interv Card Electrophysiol 25 2009 129 133
43. T. Wichter, G. Hindricks, and H. Kottkamp Catheter ablation of ventricular tachycardia A. Nava, L. Rossi, G. Thiene, Arrhythmogenic right ventricular cardiomiopathy/dysplasia 1997 Elsevier Science Amsterdam 376 391
44. G. Fontaine, J. Tonet, Y. Gallais, G. Lascault, F. Hidden-Lucet, and P. Aouate Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: a 16-year experience Curr Cardiol Rep 2 2000 498 506
45. D. Dalal, R. Jain, H. Tandri, J. Dong, S.M. Eid, and K. Prakasa Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomiopathy J Am Coll Cardiol 50 2007 432 440
46. T. Wichter, and G. Brethardt Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomiopathy: a role for genotyping in decision-making? J Am Coll Cardiol 45 2005 409 411
47. K.A. Hodgkinson, P.S. Parfrey, A.S. Bassett, C. Kupprion, J. Drenckhahn, and M.W. Norman The impact of implantable cardioverter defibrillator therapy on survival in autosomal dominant arrhythmogenic right ventricular cardiomiopathy J Am Coll Cardiol 45 2005 400 408
48. P. Brugada, and J. Brugada Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome J Am Coll Cardiol 20 1992 391 396
49. J. Brugada, R. Brugada, C. Antzelevitch, J. Towbin, K. Nademanee, and P. Brugada Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3 Circulation 105 2002 73 78
50. P. Brugada, R. Brugada, C. Antzelevitch, K. Nademanee, J. Towbin, and J. Brugada The Brugada syndrome I. Gusaak, C. Antzelevicth, Cardiac repolarization. Bridging basic and clinical sciences 2003 Human Press Totowa 427 446
51. C. Antzelevitch Brugada syndrome Pacing Clin Electrophysiol 9 2006 1130 1159
52. K. Nademanee Sudden unexplained death syndrome in southeast Asia Am J Cardiol 79 1997 10 11
53. Y. Miyasaka, H. Tsuji, K. Yamada, S. Tokunaga, D. Saito, and Y. Imuro Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan J Am Coll Cardiol 31 2001 771 774
54. D. Donohue, F. Tehrani, R. Jamehdor, C. Lam, and M.R. Movahed The prevalence of Brugada ECG in adult patients in a large university hospital in the western United States Am Heart Hosp J 6 2008 48 50
55. Q. Chen, G.E. Kirsch, D. Zhang, R. Brugada, J. Brugada, and P. Brugada Genetic basis and molecular mechanism for idiopathic ventricular fibrillation Nature 392 1998 293 296
56. H.L. Tan, C.R. Bezzina, J.P. Smits, A.O. Verkerk, and A.A. Wilde Genetic control of sodium channel function Cardiovasc Res 57 2003 961 973
57. J.R. Balser The cardiac sodium channel: gating function and molecular pharmacology J Mol Cell Cardiol 33 2001 599 613
58. R. Weiss, M.M. Barmada, T. Nguyen, J.S. Seibel, D. Cavlovich, and C.A. Kornblit Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3 Circulation 105 2002 707 713
59. B. London, M. Michale, H. Mehdi, X. Zhu, L. Kerchner, and S. Sanyal Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPDL-1) decreases cardiac Na-current and causes inherited arrhthmias Circulation 116 2007 2260 2268
60. C. Antzelevitch, G.D. Pollevick, J.M. Cordeiro, O. Casis, M.C. Sanguinetti, and Y. Aizawa Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death Circulation 115 2007 442 449
61. E. Delpón, J.M., Núñez L. Cordeiro, P.E.B. Thomsen, A. Guerchicoff, and G.D. Pollevick Functional effect of KCNE3 mutation and its role in the development of Brugada syndrome Circ Arrhythm Electrophysiol 1 2008 209 218
62. Y. Ruan, N. Liu, and S. Priori Sodium channel mutations and arrhythmias Nat Rev Cardiol 6 2009 337 348
63. M. Naomasa Phenotypic overlap of cardiac sodium channelopathies Circ J 73 2009 810 817
64. B. Benito, R. Brugada, R.M. Perich, E. Lizotte, J. Cinca, and L. Montl A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation Heart Rhythm 5 2008 1434 1440
65. P.J. Laitinen-Forsblom, P. Makynen, H. Makynen, S. Yli-Mayry, V. Virtanen, and K. Kontula SCN5A mutation associated with cardiac conduction defect and atrial arrhythmias J Cardiovasc Electrophysiol 17 2006 480 485
66. H. Morita, K. Kusano-Fukushima, S. Nagase, Y. Fujimoto, K. Hisamatsu, and H. Fujio Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome J Am Coll Cardiol 40 2002 1437 1444
67. C. Pappone, A. Radinovic, F. Manguso, G. Vicedomini, S. Sala, F.M. Sacco, and G. Ciconte New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: prevalence and clinical significance Eur Heart J. 2009 Aug 20 [Epub ahead of print]
68. G.X. Yan, and C. Antzelevitch Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation Circulation 100 1999 1660 1666
69. P.G. Meregalli, A.A. Wilde, and H.L. Tan Pathophysiological mechanisms of Brugada syndrome: depolarisation disorder, repolarisation disorder or more? Cardiovasc Res 67 2005 367 378
70. M.V. Elizari, R. Levi, R.S. Acunzo, P.A. Chiale, M. Civetta, and M. Ferreiro Abnormal expression of cardiac neural crest cells in heart development: a different hypothesis for the etiopathogenesis of Brugada syndrome Heart Rhythm 4 2007 359 365
71. A.K. Gehi, T.D. Duong, L.D. Metz, J.A. Gomes, and D. Mehta Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis J Cardiovasc Electrophysiol 17 2006 577 583
72. L. Eckardt Gender differences in Brugada syndrome J Cardiovasc Electrophysiol 18 2007 422 424
73. J.M. Di Diego, J.M. Cordeiro, R.J. Goodrow, J.M. Fish, A.C. Zygmunt, and G.J. Perez Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males Circulation 106 2002 2004 2011
74. W. Shimizu, K. Matsuo, Y. Kokubo, K. Satomi, T. Kurita, and T. Noda Sex hormone and gender difference - Role of testosterone on male predominance in Brugada syndrome J Cardiovasc Electrophysiol 18 2007 415 421
75. C. Antzelevitch, P. Brugada, M. Borggrefe, J. Brugada, R. Brugada, and D. Corrado Brugada syndrome. Report of the Second Consensus Conference Circulation 111 2005 659 670 (Pubitemid 40216496)
76. W. Shimizu, K. Matsuo, M. Takagi, Y. Tanabe, T. Aiba, and A. Taguchi Body surface distribution and response to drugs of ST segment elevation in the Brugada syndrome: clinical implication of 87-leads body surface potential mapping and its application to 12 leads electrocardiograms J Cardiovasc Electrophysiol 11 2000 396 404
77. C. Veltmann, R. Schimpf, C. Echternach, L. Eckardt, J. Kuschyk, and F. Streitner A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification Eur Heart J 27 2006 2544 2552
78. S. Richter, A. Sarkozy, G. Paparella, S. Henkens, T. Boussy, and G.B. Chierchia Number of electrocardiogram leads displaying the diagnostic coved-type pattern in Brugada syndrome: a diagnostic consensus criterion to be revised Eur Heart J. 2010 Mar 16 [Epub ahead of print]
79. A.A. Wilde Spontaneous electrocardiographic fluctuations in Brugada syndrome: does it a matter? Eur Heart J 27 2006 2493 2494
80. A. Amin, E. De Groot, J. Ruijter, A. Wilde, and H. Tan Exerciseinduced ECG changes in Brugada syndrome Circ Arrhythmia Electrophysiol 2 2009 531 539
81. K. Hong, J. Brugada, A. Oliva, A. Berruezo-Sanchez, D. Potenza, and G.D. Pollevick Value of electrocardiographic parameters and ajmaline. Test in the diagnosis of Brugada syndrome caused by SCN5A Circulation 110 2004 3023 3027
82. S.G. Priori, C. Napolitano, M. Gasparini, C. Pappone, P. Della Bella, and U. Giordano Natural history of brugada syndrome: insights for risk stratification and management Circulation 105 2002 1342 1347 (Pubitemid 34260426)
83. S.G. Priori, and C. Napolitano Management of patients with Brugada syndrome should be not based on programmed electrical stimulation Circulation 112 2005 279 292
84. J. Brugada, R. Brugada, and P. Brugada Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest Circulation 108 2003 3092 3096
85. G. Paparella, A. Sarkozy, and P. Brugada Brugada syndrome: the prognostic dilemma and value of syncope Minerva Med 100 2009 307 319
86. A. Gehi, T. Duong, L. Metz, J. Gomes, and D. Metha Risk stratification of individuals with the Brugada electrocardiogram: a metaanalysis J Cardiovasc Electrophysiol 17 2006 577 583
87. P. Brugada, R. Brugada, and J. Brugada Should patients with asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 112 2005 279 292
88. A. Sarkozy, T. Boussy, G. Kourgiannides, G. Chierchia, S. Richter, and T. De Potter Long-term follow up of primary prophylactic implantable cardioverter-defibrillator theraphy in Brugada syndrome Eur Heart J 28 2007 334 344
89. F. Sacher, V. Probst, Y. Iesaka, P. Jacon, J. Laborderie, and F. Mizon- Gerard Outcome after implantation of a cardioverterdefibrillator in patients with Brugada syndrome Circulation 114 2006 2317 2322
90. J.S. Hermida, I. Denjoy, J. Clerc, F. Extramiana, G. Jerry, and P. Milliez Hydroquinidine therapy in Brugada syndrome J Am Coll Cardiol 43 2004 1853 1860
91. S. Joshi, and D.J. Wilber Ablation of idiopathic right ventricular outflow tract tachycardia: current perspectives J Cardiovasc Electrophysiol 16 Suppl 1 2005 S52 S58
92. J.M. Miller, N.G. Pezeshkian, and A.V. Yadav Catheter mapping and ablation of right ventricular outflow tract ventricular tachycardia J Cardiovasc Electrophysiol 17 2006 800 802
93. W.M. Miles Idiopathic ventricular outflow tract tachycardia: where does it originate J Cardiovasc Electrophysiol 12 2001 536 537
94. W.G. Stevenson, and K. Soejima Catheter ablation for ventricular tachycardia Circulation 115 2007 2750 2760
95. D.J. Wilber, J. Baerman, B. Olshansky, J. Kall, and D. Kopp Adenosine sensitive ventricular tachycardia: clinical characteristics and response to catheter ablation Circulation 87 1993 126 134
96. M. Nakagawa, N. Takahashi, S. Nobe, M. Ichinose, T. Ooie, and F. Yufu Gender differences in various types of idiopathic ventricular tachycardia J Cardiovasc Electrophysiol 13 2002 633 638
97. P. Coumel, J.F. Leclercq, and R. Slama Repetitive monomorphic idiopathic ventricular tachycardia D.P. Zipes, J. Jalife, Cardiac electrophysiology and arrhythmias 1985 Grune-Stratton Orlando 457 468
98. D. O'Donnel, D. Cox, J. Bourke, L. Mitchell, and S. Furniss Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia Eur Heart J 24 2003 801 810
99. F. Gaita, C. Giustetto, P. Di Donna, E. Richiardi, L. Libero, and M.C. Brusin Long-term follow-up of right ventricular monomoprhic extrasystoles J Am Coll Cardiol 38 2001 364 370
100. T. Noda, W. Shimizu, A. Taguchi, T. Aiba, K. Satomi, K. Suyama, and T. Kurita Malignant entity of idiopathic ventricular fibrillation and polymorphyc ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract J Am Coll Cardiol 46 2005 1288 1294
101. S. Viskin, R. Rosso, O. Rogowski, and B. Belhassen The short coupled variant of right ventricular outflow tachycardia. A not so benign form of benign ventricular tachycardia J Cardiovasc Electrophysiol 16 2005 912 916
102. W. Shimizu Arrhythmias originating from the right ventricle outflow tract: how to distinguish "malignant" from "benign" Heart Rhythm 6 2009 1507 1511
103. B.B. Lerman, L. Belardinelli, G.A. West, R.M. Berne, and J.P. DiMarco Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity Circulation 74 1986 270 280
104. J.G. Murphy, B.J. Gersh, D.D. Mair, V. Fuster, M.D. McGoon, and D.M. Ilstrup Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot N Engl J Med 329 1993 593 599
105. M. Chinushi, Y. Aizawa, H. Kitazawa, Y. Kusano, T. Washizuka, and A. Shibata Successful radiofrequency catheter ablation for macroreentrant ventricular tachycardias in a patient with tetralogy of Fallot after corretive surgery Pacing Clin Electrophysiol 18 1995 1713 1716
106. W.G. Stevenson, E. Delacretaz, P.L. Friedman, and K.E. Ellison Identification and ablation of macroreentrant ventricular tachycardia with the CARTO electroanatomival mapping system Pacing Clin E lectrophysiol 21 1998 1448 1456
107. D. Harrison, L. Harris, S.et. Siu, C.J. MacLoghlin, M.S. Connelly, and G.D. Webb Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot J Am Coll Cardiol 30 1997 1368 1373
108. M.A. Gatzoulis, S. Balaji, S.A. Webber, S.C. Siu, J.S. Hokanson, and C. Poile Risk factors for arrhyhtmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study Lancet 356 2000 975 981
109. G. Nollert, T. Fischlein, S. Bouterwek, C. Bohmer, W. Klinner, and B. Reichart Long-term survival in patients with repair of tetralogy of Fallot: 36 years follow up of 490 of the first year after surgical repair J Am Coll Cardiol 30 1997 1374 1383
110. K. Zeppenfeld, M. Schalij, M. Bartelings, U. Tedrow, B. Koplan, and K. Soejima Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus Circulation 116 2007 2241 2325
111. D. Corrado, and G. Thiene Routine screening of all athletes prior to participation in competitive sports should be mandatory to prevent sudden cardiac death Heart Rhythm 4 2007 520 524
112. A. Pelliccia, F. Di Paolo, F. Quattrini, C. Basso, F. Culasso, and G. Popoli Outcomes in athletes with marked ECG repolarization abnormalities N Engl J Med 358 2008 152 161
113. D. Corrado, C. Basso, and G. Thiene Pathological findings in victims of sport-related sudden cardiac death Sports Exerc Injury 2 1996 78 86
114. C.M. Albert, M.A. Mittleman, C.U. Chae, I.M. Lee, C.H. Hennkens, and J.E. Manson Triggering of sudden death from cardiac causes by vigorous exertion N Engl J Med 343 2000 1355 1361
115. H.D. Esperer, O. Hoos, and K. Hottenrott Syncope due to Brugada syndrome in a young athlete Br J Sports Med 41 2007 180 181
116. A. Grimster, O.R. Segal, and E.R. Behr Type 1 Brugada electrocardiogram pattern during the recovery phase of exercise testing Europace 10 2008 897 898
117. M. García-Borbolla, R. García-Borbolla, L.F. Valenzuela, and F. Trujillo Taquicardia ventricular inducida por prueba de esfuerzo en paciente con síndrome de Brugada Rev Esp Cardiol 60 2007 993 994
118. B.J. Maron, and D.P. Zipes 36th Bethseda Conference: Eligibility recommendations for competitive athletes with cardiovascular abnormalities J Am Coll Cardiol 45 2005 1313 1375
119. R. Lampert, D. Cannon, and B. Olshansky Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society members J Cardiovasc Electrophysiol 17 2006 11 15